Duration of Contact Precautions in Acute Care Settings
Key Points
Key Points
Recommendations herein are based on synthesis of limited evidence, theoretical rationale, current practices, practical considerations, the opinion of the writing group, consideration of potential harms, and a survey of 134 institutions within the SHEA Research Network, 26% of which are outside the United States and Canada.
Methicillin-Resistant Staphylococcus aureus (MRSA)
...Methicillin-Resista...
...hospital uses CP for patients previousl...
For patients not on antimicrobial therapy w...
...-risk patients, such as those with chronic wou...
...an outbreak setting, if a facility’s...
Vancomycin-Resistant Enterococci (VRE)
...V...
...ospital uses CP when caring for patients...
...mmends that, following treatment of VRE infection,...
...hould consider extending CP prior to assessing...
...tbreak setting and if facility endemic rates of...
Multidrug-Resistant Enterobacteriaceae (MDR-E)
...Multid...
...ses CP for patients infected or colonized with MD...
...that for extensively drug-resistant Enterobac...
Clostridium difficile
...Clostridium diffi...
...ends that patients with C. difficile infection (CD...
...tals should consider extending CP through the dura...
...t this time, insufficient evidence...
Microbiological Screening and Molecular Testing
...Microbiologic...
...s time, insufficient evidence exists to ma...